Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18696528 | A SYSTEM AND METHOD FOR DETERMINING THE VASCULAR ENDOTHELIUM FUNCTIONALITY OF AN ARTERY | March 2024 | February 2025 | Allow | 11 | 1 | 0 | Yes | No |
| 18380259 | SYRINGE-BASED FLUID DIVERSION MECHANISM FOR BODILY FLUID SAMPLING | October 2023 | May 2024 | Allow | 7 | 2 | 0 | Yes | No |
| 18033179 | ELECTRICAL IMPEDANCE IMAGING METHOD, SYSTEM, STORAGE MEDIUM, AND ELECTRONIC DEVICE | April 2023 | November 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18147086 | METHOD AND APPARATUS FOR PROVIDING A MULTI-DIMENSIONAL AUDIOGRAM | December 2022 | September 2023 | Allow | 9 | 2 | 0 | Yes | No |
| 18073923 | UPPER COIL ASSEMBLY OF AN RF PROBE FOR USE IN AN MRI SYSTEM | December 2022 | February 2025 | Allow | 27 | 1 | 0 | No | No |
| 17937072 | BLOOD SEQUESTRATION DEVICE AND METHOD | September 2022 | March 2024 | Allow | 18 | 1 | 0 | Yes | No |
| 17888722 | FORCEPS WITH LOCKING MECHANISM | August 2022 | January 2025 | Allow | 29 | 2 | 0 | Yes | No |
| 17847427 | Hypodermic Needle That Mitigates Blood Vessel Collapse | June 2022 | May 2024 | Allow | 23 | 5 | 0 | Yes | No |
| 17833728 | SYSTEMS AND METHODS FOR IDENTIFYING TURNS | June 2022 | February 2024 | Abandon | 20 | 1 | 0 | No | No |
| 17628441 | SMALL BLOOD VISCOSITY MEASUREMENT KIT AND CARTRIDGE THEREFOR | January 2022 | March 2025 | Allow | 38 | 1 | 1 | No | No |
| 17568232 | COMMUNICATION DEVICE AND COMMUNICATION SYSTEM FOR MONITORING BREATHING | January 2022 | April 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17534733 | SYSTEM, METHOD, AND APPARATUS FOR SEXUAL PERFORMANCE SENSING | November 2021 | December 2024 | Abandon | 37 | 2 | 0 | No | No |
| 17496858 | Blood Draw Syringe With Hemolysis Protection | October 2021 | April 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17496292 | Intravenous Catheter Device Having a Probe Assembly With an Integrated Fluid Flushing Mechanism | October 2021 | March 2025 | Allow | 41 | 4 | 0 | Yes | No |
| 17398634 | CATHETER AND RETRACTABLE NEEDLE WITH PURGING SYSTEM | August 2021 | February 2024 | Abandon | 30 | 1 | 0 | No | No |
| 17382271 | HIGH TORQUE GUIDEWIRE DEVICE | July 2021 | March 2025 | Allow | 43 | 2 | 0 | No | No |
| 17378813 | METHOD FOR DETECTING GAIT EVENTS BASED ON ACCELERATION | July 2021 | February 2025 | Abandon | 43 | 3 | 0 | No | No |
| 17375711 | IMPLANT FOR DETERMINING INTRAOCULAR PRESSURE | July 2021 | January 2025 | Allow | 42 | 3 | 0 | Yes | No |
| 17311400 | SENSORIZED GARMENT | June 2021 | March 2025 | Allow | 45 | 2 | 0 | Yes | No |
| 17338499 | Electronic Devices With 6 Minute Walk Distance Estimates | June 2021 | December 2023 | Allow | 30 | 2 | 0 | Yes | No |
| 17315427 | ROBOT FOR VASCULAR INTERVENTION | May 2021 | January 2024 | Allow | 32 | 1 | 0 | No | No |
| 17236816 | SYSTEM AND METHOD FOR IMAGING, SEGMENTATION, TEMPORAL AND SPATIAL TRACKING, AND ANALYSIS OF VISIBLE AND INFRARED IMAGES OF OCULAR SURFACE AND EYE ADNEXA | April 2021 | October 2024 | Abandon | 42 | 2 | 0 | Yes | No |
| 17277616 | SPREADING DEPOLARIZATION AND REPOLARIZATION AS BIOMARKERS OF NEUROLOGICAL RECOVERY AFTER CARDIAC ARREST | March 2021 | April 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17272767 | ARTERIAL BLOOD GAS COLLECTION SYSTEM | March 2021 | July 2025 | Allow | 52 | 6 | 0 | Yes | Yes |
| 17183098 | INSTRUMENT DELIVERY DEVICES, SYSTEMS, AND METHODS TO EXTEND THROUGH A THROMBUS | February 2021 | July 2024 | Allow | 40 | 1 | 1 | Yes | No |
| 17180524 | DEVICE FOR TISSUE HARVESTING FOR BIOPSY EXAMINATION | February 2021 | July 2024 | Abandon | 41 | 2 | 0 | No | No |
| 17178816 | Three-Dimensional Printed Swabs for Diagnostic Testing | February 2021 | October 2024 | Abandon | 44 | 2 | 1 | No | No |
| 17154182 | DECISION SUPPORT AND TREATMENT ADMINISTRATION SYSTEMS | January 2021 | February 2024 | Allow | 36 | 3 | 0 | Yes | No |
| 17258582 | Pulse-Wave Signal Analysis Device, Pulse-Wave Signal Analysis Method and Computer Program | January 2021 | August 2024 | Allow | 43 | 3 | 0 | No | No |
| 16973207 | METHOD AND SYSTEM FOR DETERMINING TOUCH SENSITIVITY THRESHOLD | December 2020 | September 2024 | Allow | 45 | 3 | 0 | No | No |
| 17085034 | Configurable Fashion Accessory Including an Electronic System for Activity Tracking | October 2020 | December 2023 | Abandon | 37 | 1 | 0 | No | No |
| 17051339 | Squeeze Activated Blood Collection Set | October 2020 | May 2024 | Allow | 42 | 3 | 0 | No | No |
| 17032869 | ROTATION BIOPSY SYSTEM AND HANDLE | September 2020 | January 2025 | Allow | 52 | 5 | 0 | Yes | No |
| 17020809 | APPARATUS AND METHOD FOR EVALUATING FORCE CONTROL ABILITY OF UPPER LIMB AND PROSTHESIS | September 2020 | June 2025 | Allow | 57 | 8 | 0 | Yes | No |
| 17006970 | BLOODLETTING SYRINGE, BLOODLETTING SYRINGE SYSTEM AND BLOODLETTING METHODS | August 2020 | August 2023 | Abandon | 35 | 1 | 0 | No | No |
| 16999251 | System and Method for Providing Real-Time Feedback Related to Fitness Training | August 2020 | July 2023 | Abandon | 35 | 1 | 0 | No | No |
| 16997526 | CATHETER SYSTEM TO FACILITATE BLOOD SAMPLING AND RELATED METHODS | August 2020 | November 2023 | Allow | 39 | 3 | 0 | Yes | No |
| 16938644 | SYSTEM, METHOD, AND COMPUTER READABLE MEDIUM FOR MONITORING, TRACKING, AND TRACING TEMPERATURE AND HUMIDITY UNDER GARMENT | July 2020 | April 2023 | Allow | 33 | 2 | 0 | Yes | No |
| 16924773 | ELECTRICAL NODE WITH MONITORING FEATURE | July 2020 | May 2025 | Abandon | 59 | 2 | 1 | No | No |
| 16955035 | TISSUE ELASTICITY MEASUREMENT | June 2020 | March 2023 | Allow | 33 | 1 | 0 | Yes | No |
| 16772855 | WEARABLE OR INSERTABLE DEVICES WITH MICRONEEDLES THAT INCLUDE MECHANICALLY-RESPONSIVE MATERIAL | June 2020 | May 2023 | Abandon | 35 | 1 | 0 | No | No |
| 16885799 | PRESSURE MEASUREMENT DEVICE FOR MEASURING PRESSURE AND/OR FOR MEASURING ELASTICITY OF A VEIN OR AN ORGAN AND FOR COMBINATION WITH AN ULTRASOUND MEASUREMENT UNIT, PRESSURE MEASUREMENT SYSTEM, AND METHOD | May 2020 | December 2023 | Allow | 43 | 1 | 1 | No | No |
| 16863067 | CATHETER WITH REMOVABLE VISION PROBE | April 2020 | February 2023 | Allow | 33 | 2 | 0 | Yes | No |
| 16757048 | POINT-OF-CARE SYSTEM FOR DETECTION OF THE PHYSICAL STRESS AT DIFFERENT PARTS OF BODY | April 2020 | April 2024 | Abandon | 48 | 4 | 0 | No | No |
| 16837218 | WEARABLE COMPUTING DEVICES FOR ACQUIRING ATHLETIC MOVEMENT DATA, AND SYSTEMS AND METHODS RELATING THERETO | April 2020 | April 2023 | Abandon | 36 | 1 | 0 | No | No |
| 16824354 | APNEIC/HYPOPNEIC ASSESSMENT VIA PHYSIOLOGICAL SIGNALS | March 2020 | November 2023 | Allow | 44 | 2 | 1 | Yes | No |
| 16803672 | SYSTEMS AND METHODS FOR DETECTING ATRIAL TACHYARRHYTHMIA | February 2020 | October 2022 | Allow | 32 | 1 | 0 | Yes | No |
| 16792057 | METHODS AND SYSTEMS FOR PULMONARY CONDITION ASSESSMENT | February 2020 | October 2023 | Allow | 45 | 5 | 0 | Yes | No |
| 16788366 | Ascertaining, Reporting, and Influencing Physical Attributes And Performance Factors of Athletes | February 2020 | April 2024 | Abandon | 50 | 3 | 0 | No | No |
| 16747144 | Moveable MRI System RF Coil Arrangement | January 2020 | March 2023 | Allow | 37 | 2 | 0 | Yes | No |
| 16742035 | INTRAVENOUS THERAPY SYSTEM FOR BLOOD VESSEL DETECTION | January 2020 | March 2023 | Allow | 38 | 1 | 0 | Yes | No |
| 16630344 | Biological Fluid Collection Device | January 2020 | September 2024 | Allow | 57 | 6 | 0 | No | No |
| 16734511 | BIOPSY INSTRUMENT WITH INK-FILLED MEMBRANE | January 2020 | June 2022 | Allow | 29 | 1 | 0 | Yes | No |
| 16720589 | METHODS FOR SENSING AND ANALYZING IMPACTS AND PERFORMING AN ASSESSMENT | December 2019 | December 2024 | Abandon | 60 | 4 | 0 | No | No |
| 16622692 | DETECTING ACTIVITY IN PERIPHERAL NERVES | December 2019 | January 2024 | Abandon | 50 | 4 | 0 | Yes | No |
| 16622743 | STRAIN GAUGE, PRESSURE SENSOR, AND INTERVENTIONAL MEDICAL CATHETER | December 2019 | October 2022 | Allow | 35 | 1 | 0 | Yes | No |
| 16708498 | VARIABLE STIFFNESS INTRALUMINAL DEVICE | December 2019 | December 2024 | Abandon | 60 | 5 | 1 | No | No |
| 16699809 | System and Method for Oral Health Monitoring Using Electrical Impedance Tomography | December 2019 | December 2024 | Allow | 60 | 7 | 0 | Yes | Yes |
| 16616238 | EXERGAMING FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) | November 2019 | May 2024 | Abandon | 54 | 5 | 0 | No | No |
| 16684424 | SYSTEMS AND METHODS FOR IDENTIFYING TURNS | November 2019 | August 2022 | Abandon | 33 | 1 | 0 | No | No |
| 16669412 | Methods and Devices for Selecting Miniaturized Impedance Electrodes of Miniaturized Impedance Sensors | October 2019 | April 2023 | Allow | 41 | 3 | 1 | Yes | No |
| 16592342 | STRETCHING DEVICE AND METHODS RELATING TO SAME | October 2019 | June 2024 | Allow | 56 | 5 | 0 | Yes | No |
| 16586326 | DEVICES AND METHODS FOR PHLEBOTOMY THROUGH A CLOSED SYSTEM INTRAVENOUS CATHETER | September 2019 | November 2023 | Allow | 50 | 3 | 1 | No | No |
| 16482075 | LIPID MEASURING APPARATUS AND LIPID MEASURING METHOD | July 2019 | January 2023 | Abandon | 42 | 3 | 0 | Yes | No |
| 16479192 | DISCRETE BIOELECTRICAL IMPEDANCE IDENTIFICATION DEVICE | July 2019 | August 2022 | Allow | 37 | 1 | 1 | Yes | No |
| 16509878 | BIOPSY DEVICE WITH SELF-REVERSING CUTTER DRIVE | July 2019 | April 2023 | Allow | 45 | 2 | 1 | Yes | No |
| 16475741 | DISPOSABLE NEEDLE BIOPSY DEVICE AND NEEDLE STRUCTURE OF CUTTING BIOPSY APPARATUS | July 2019 | October 2022 | Abandon | 39 | 0 | 1 | No | No |
| 16447266 | Training System for Tourniquet Application | June 2019 | December 2022 | Abandon | 42 | 1 | 0 | No | No |
| 16444088 | Capturing and Analyzing Hypoglycemic Event Data to Identify Treatment Options | June 2019 | August 2022 | Allow | 38 | 1 | 0 | Yes | No |
| 16434284 | BLOOD SEQUESTRATION DEVICE AND METHOD | June 2019 | August 2023 | Allow | 50 | 2 | 1 | Yes | No |
| 16464739 | INGESTIBLE DEVICE RECOVERY SYSTEM | May 2019 | August 2022 | Allow | 39 | 1 | 1 | Yes | No |
| 16390499 | Blood Collection Assembly | April 2019 | August 2022 | Allow | 40 | 2 | 0 | Yes | No |
| 16373384 | APPARATUS AND METHODS FOR PERFORMING A DENTAL COLD SENSITIVITY TEST AND FOR CONTROLLING SWAB SATURATION | April 2019 | April 2024 | Abandon | 60 | 4 | 0 | No | No |
| 16325765 | WEARABLE MEDICAL DEVICE AND SYSTEMS DERIVED THEREFROM | February 2019 | December 2022 | Abandon | 46 | 2 | 0 | No | No |
| 16269576 | System and method for optimized monitoring of joints in physiotherapy | February 2019 | February 2025 | Abandon | 60 | 5 | 0 | No | No |
| 16215770 | CLAMPING DEVICE FOR DETECTING INTERNAL BLOOD PRESSURE | December 2018 | September 2022 | Allow | 45 | 2 | 0 | Yes | No |
| 16140627 | SURGICAL INSTRUMENTS INCLUDING DEVICES FOR SENSING TISSUE PROPERTIES AND METHODS THEREOF | September 2018 | September 2022 | Allow | 48 | 1 | 0 | Yes | No |
| 15604792 | SYSTEMS FOR REAL TIME FEBRILITY DETECTION AND NOTIFICATION | May 2017 | November 2024 | Allow | 60 | 6 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PATEL, OM.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner PATEL, OM works in Art Unit 3791 and has examined 77 patent applications in our dataset. With an allowance rate of 64.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.
Examiner PATEL, OM's allowance rate of 64.9% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PATEL, OM receive 2.48 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by PATEL, OM is 41 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +63.6% benefit to allowance rate for applications examined by PATEL, OM. This interview benefit is in the 98% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 22.1% of applications are subsequently allowed. This success rate is in the 18% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 41.9% of cases where such amendments are filed. This entry rate is in the 57% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 54.5% are granted (fully or in part). This grant rate is in the 69% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 44% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.